because more studies have reported bacteriological and clinical relapses with ethylsuccinate and stearate formulations than with the estolate preparation , erythromycin estolate 50 mg/kg/d in divided doses over a 14-day period is recommended for the treatment of pertussis .
C0014809
erythromycin estolate
C0043167
pertussis